The Orthopaedic Implant Company (OIC) is participating in a pilot program led by Intermountain Healthcare, which has thus far led to a $3.6MM reduction on supply expenses for the Integrated Delivery Network (IDN).
Intermountain Healthcare in Utah is a not-for-profit system of 24 hospitals, 160 clinics, a medical group with 2,300 physicians and advanced care practitioners, a health insurance company and other health services.
“The future of U.S. healthcare can only be successful if we continue to strive for optimal outcomes while greatly improving value,” said Itai Nemovicher, President and CEO at OIC.
IDNs are a popular discussion topic, given their mission to improve the patient experience and care outcomes while reducing cost. In his quarterly column for ORTHOKNOW®, Patrick Vega touches on them quite frequently. As IDNs emerge, they cause device companies to shift skill sets beyond supporting the surgeon in the O.R. and negotiating for pricing, toward expanded knowledge of hospital departments, cost containment strategies and clinical use of their products for patient care. Earlier this year, Mr. Vega shared expertise in Hospital Trends: What Hospitals Want Orthopedic Manufacturers to Know.
The Orthopaedic Implant Company (OIC) is participating in a pilot program led by Intermountain Healthcare, which has thus far led to a $3.6MM reduction on supply expenses for the Integrated Delivery Network (IDN).
Intermountain Healthcare in Utah is a not-for-profit system of 24 hospitals, 160 clinics, a medical group with 2,300 physicians and...
The Orthopaedic Implant Company (OIC) is participating in a pilot program led by Intermountain Healthcare, which has thus far led to a $3.6MM reduction on supply expenses for the Integrated Delivery Network (IDN).
Intermountain Healthcare in Utah is a not-for-profit system of 24 hospitals, 160 clinics, a medical group with 2,300 physicians and advanced care practitioners, a health insurance company and other health services.
“The future of U.S. healthcare can only be successful if we continue to strive for optimal outcomes while greatly improving value,” said Itai Nemovicher, President and CEO at OIC.
IDNs are a popular discussion topic, given their mission to improve the patient experience and care outcomes while reducing cost. In his quarterly column for ORTHOKNOW®, Patrick Vega touches on them quite frequently. As IDNs emerge, they cause device companies to shift skill sets beyond supporting the surgeon in the O.R. and negotiating for pricing, toward expanded knowledge of hospital departments, cost containment strategies and clinical use of their products for patient care. Earlier this year, Mr. Vega shared expertise in Hospital Trends: What Hospitals Want Orthopedic Manufacturers to Know.
Copy to clipboard 
